Can Lam Research Outrun Teradyne in the Next Rally?

TER: Teradyne logo
TER
Teradyne

Teradyne surged 19% during the past Month. You may be tempted to buy more, or may want to reduce your exposure. But there is an entirely different perspective you might be missing. Is there a better alternative? Turns out, its peer Lam Research gives you more. Lam Research (LRCX) stock offers superior revenue growth across key periods, better profitability, and relatively lower valuation vs Teradyne (TER) stock, suggesting you may be better off investing in LRCX

  • LRCX’s quarterly revenue growth was 27.7%, vs. TER’s 4.3%.
  • In addition, its Last 12 Months revenue growth came in at 25.7%, ahead of TER’s 4.5%.
  • LRCX leads on profitability over both periods – LTM margin of 33.0% and 3-year average of 30.2%.

These differences become even clearer when you look at the financials side by side. The table highlights how TER’s fundamentals stack up against those of LRCX on growth, margins, momentum, and valuation multiples.

Valuation & Performance Overview

  TER LRCX Preferred
     
Valuation      
P/EBIT Ratio 58.5 34.8 LRCX
     
Revenue Growth      
Last Quarter 4.3% 27.7% LRCX
Last 12 Months 4.5% 25.7% LRCX
Last 3 Year Average -4.3% 4.0% LRCX
     
Operating Margins      
Last 12 Months 18.8% 33.0% LRCX
Last 3 Year Average 19.4% 30.2% LRCX
     
Momentum      
Last 3 Year Return 132.7% 345.8% TER

Note: For “Last 3 Year Return” metric, preferred stock is one with higher returns unless the returns are too high (>300%) which creates risk of sell off.
See more revenue details: TER Revenue Comparison | LRCX Revenue Comparison
See more margin details: TER Operating Income Comparison | LRCX Operating Income Comparison

Relevant Articles
  1. What To Expect From Johnson & Johnson Stock?
  2. What To Expect From Microsoft Stock?
  3. The Smart Way to Own ANET: Collect 10% Before You Even Buy
  4. Triggers That Could Ignite the Next Rally In Meta Platforms Stock
  5. Can Coca-Cola Stock Withstand These Pressures?
  6. Fiserv Stock: Strong Cash Flow Poised for a Re-Rating?

See detailed fundamentals on Buy or Sell LRCX Stock and Buy or Sell TER Stock. Below we compare market return and related metrics across years.

Historical Market Performance

  2020 2021 2022 2023 2024 2025 Total [1] Avg Best
Returns
TER Return 77% 37% -46% 25% 17% 58% 199%    
LRCX Return 64% 54% -41% 89% -7% 148% 551%   <===
S&P 500 Return 16% 27% -19% 24% 23% 18% 114%  
Monthly Win Rates [3]
TER Win Rate 58% 58% 50% 58% 67% 67%   60%  
LRCX Win Rate 67% 67% 33% 58% 42% 58%   54%  
S&P 500 Win Rate 58% 75% 42% 67% 75% 73%   65% <===
Max Drawdowns [4]
TER Max Drawdown -35% -13% -56% -5% -12% -46%   -28%  
LRCX Max Drawdown -36% 0% -56% -1% -10% -18%   -20%  
S&P 500 Max Drawdown -31% -1% -25% -1% -2% -15%   -12% <===

[1] Cumulative total returns since the beginning of 2020
[2] 2025 data is for the year up to 12/26/2025 (YTD)
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year

No matter how good the numbers, stock investment is never a smooth ride. There is a risk you must factor in. Read LRCX Dip Buyer Analyses and TER Dip Buyer Analyses to see how these stocks have fallen and recovered in the past.

Still not sure about TER or LRCX? Consider portfolio approach.

Portfolios Are The Smarter Way To Invest

Individual stocks are unpredictable. A smart portfolio keeps you invested, limits downside shocks, and provides upside exposure

The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 – the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.